Key Insights

Highlights

Treatment Research

2 treatments under study, led by Intervention 1 2 Lignocaine 180000 Epinephrine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Intervention 1 2 Lignocaine 180000 Epinephrine1
  • Intervention 2 4articaine 1100000 Epinephrine1

Active Sponsors

  • Armed Forces Institute of Dentistry, Pakistan1

Activity Timeline